| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
449,967 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$81,866,696 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
69 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Akkaraju Srinivas |
Director |
– • – |
2008-09-22 |
4 |
S |
$12.79 |
$237,907 |
I/I |
(18,601) |
600,559 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-09-19 |
4/A |
S |
$12.74 |
$1,117,247 |
I/I |
(87,696) |
603,588 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-09-19 |
4 |
S |
$12.74 |
$471,520 |
I/I |
(37,011) |
603,588 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-09-18 |
4/A |
S |
$12.71 |
$627,594 |
I/I |
(49,378) |
617,871 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-09-18 |
4 |
S |
$12.71 |
$264,864 |
I/I |
(20,839) |
617,871 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2008-09-16 |
4 |
S |
$12.25 |
$367,455 |
D/D |
(30,000) |
33,427 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2008-09-16 |
4 |
OE |
$4.45 |
$139,700 |
D/D |
30,000 |
53,427 |
|
- |
|
| Rosenberg Morris |
Sr. VP, Development |
• – – |
2008-08-04 |
4 |
S |
$11.30 |
$564,975 |
D/D |
(50,000) |
0 |
|
- |
|
| Rosenberg Morris |
Sr. VP, Development |
• – – |
2008-08-04 |
4 |
OE |
$6.72 |
$336,000 |
D/D |
50,000 |
50,000 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2008-08-01 |
4 |
OE |
$3.00 |
$45,000 |
D/D |
15,000 |
968,168 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-07-29 |
4 |
S |
$10.85 |
$1,038,215 |
I/I |
(95,688) |
625,913 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-07-28 |
4 |
S |
$10.36 |
$219,964 |
I/I |
(21,232) |
685,702 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-07-25 |
4 |
S |
$10.81 |
$1,601,350 |
I/I |
(148,136) |
701,432 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2008-07-25 |
4 |
S |
$10.78 |
$1,077,790 |
D/D |
(100,000) |
953,168 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-05-16 |
4 |
S |
$10.39 |
$436,993 |
I/I |
(42,059) |
811,175 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-05-15 |
4 |
S |
$10.14 |
$1,001,406 |
I/I |
(98,758) |
842,334 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-05-14 |
4 |
S |
$10.10 |
$1,225,787 |
I/I |
(121,365) |
915,496 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2008-05-13 |
4 |
S |
$10.06 |
$512,014 |
I/I |
(50,896) |
1,005,407 |
|
- |
|
| Baker Felix |
Director |
– • • |
2008-03-18 |
4 |
B |
$8.02 |
$142,732 |
I/I |
17,793 |
3,974,756 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-03-18 |
4 |
B |
$8.02 |
$1,131 |
I/I |
141 |
477,382 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-03-18 |
4 |
B |
$8.02 |
$13,420 |
I/I |
1,673 |
156,903 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-03-18 |
4 |
B |
$8.02 |
$423,038 |
I/I |
52,736 |
7,937,438 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-03-17 |
4 |
B |
$7.80 |
$186,231 |
I/I |
23,873 |
3,956,963 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-03-17 |
4 |
B |
$7.80 |
$1,474 |
I/I |
189 |
477,241 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-03-17 |
4 |
B |
$7.80 |
$17,513 |
I/I |
2,245 |
155,230 |
2.17 |
- |
|
1805 Records found
|
|
Page 56 of 73 |
|
|
